4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001209191-22-034044
Options or other derivatives
- Director acquired 8,293 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| GRAY MARY ANN Director | 2022-06-01 | Grant or award · Stock Options (right to buy) | +8,293 | 8,293 | D | ||
Loading xslF345X03/doc4.xml…